Considering the high proliferation and metastatic rates of hepatoma cells induced by the SPZ1–TWIST1 axis, we next evaluated the potential effects of inhibitors or modulators of upstream (RTK signaling) [11] or downstream (VEGF signaling involving the SPZ1–TWIST1 complex) pathways. Here, TWIST1 is linked to hepatocellular carcinoma.